Nitrile Glove Accelerators: Thiuram, Carbamates and Contact Dermatitis
A dental hygienist in Mississauga wears gloves for six hours a day. By Wednesday her knuckles itch, by Thursday there is a red, slightly raised band across the back of both hands, and by Friday she has switched to a box of gloves someone found in a cupboard. The rash fades over the weekend. It comes back the following Wednesday.
She has been told she is allergic to latex. She has not worn latex in four years.
That gap — between what people believe about glove reactions and what is actually happening on the skin — is the most expensive confusion in clinic PPE. It leads to staff buying their own gloves, to clinics switching brands on rumour, and to a genuine occupational skin problem being managed as a personality trait.
Why do nitrile gloves cause a rash if there is no latex in them?
Nitrile is a synthetic rubber. It has no natural rubber latex protein, which is the allergen behind the immediate, sometimes severe type I reaction that forced most of the healthcare sector off latex in the 1990s. That is genuine progress and it is why nitrile became the default exam glove in Canadian clinics.
But a glove is not only its polymer. Nitrile film is cured, and curing needs accelerators: thiurams, dithiocarbamates, thiazoles and related compounds. Residues stay in the finished film, and the warm, damp environment inside a glove is very good at leaching them out. Add occlusion, friction at the knuckles, and the fact that many clinicians change gloves fifteen times before lunch, and the conditions for a delayed allergic reaction are set.
Which means a clinician wearing a powder-free nitrile glove can still be reacting to the glove — just not to latex. It also means the glove line is a variable a clinic can change deliberately, and that is where a documented, consistent product such as the Aurelia Protege 4.0 mil powder-free nitrile glove becomes useful: one change at a time, on a product whose specification does not move between lots.
What are the accelerators and which ones actually cause trouble?
The two families that appear most often in glove-related patch test results are thiurams and dithiocarbamates.
Thiurams are sulfur-containing accelerators used across the rubber industry, and they are notorious enough that a thiuram mix sits in most standard patch test series. Dithiocarbamates — zinc dibutyldithiocarbamate is the one most often named — are the accelerator family more closely associated with nitrile in particular, because they cure fast at low temperature, which suits thin film production.
Neither is present in large amounts. That is exactly what makes the problem hard to see: a residue measured in parts per million can be enough to sensitise a wearer over months of daily exposure, and once sensitised, the reaction can be triggered by contact levels far below what caused the original sensitisation.
The practical consequence for a buyer is that the label on the box does not tell you. Neither does the word nitrile, and neither does powder-free. A supplier asking a manufacturer for the accelerator package is asking a reasonable question; a supplier who cannot answer it is telling you something too.
How do you separate a reaction from ordinary irritation?
Three distinctions do most of the work in a treatment room, and none of them requires a dermatologist to make a first pass.
| Pattern | Typical timing | Where it appears | What usually helps |
|---|---|---|---|
| Irritant contact dermatitis | During or right after wear | Web spaces, palms, under a ring | Shorter wear, drier hands, less harsh soap |
| Type IV allergic reaction | 12 to 72 hours after exposure | Back of hands, knuckles, wrist, spreading | Change of glove chemistry, patch testing |
| Type I latex allergy | Minutes | Hives, itch, sometimes systemic | Latex-free environment, medical review |
The timing column is the one people get wrong. A rash that appears on Friday evening for a Monday-to-Friday clinician is unlikely to be a same-day irritant response and much more likely to be delayed hypersensitivity. A rash that appears mid-shift and settles by the evening usually points at occlusion, soap or friction.
Distribution matters as much. Irritation clusters where sweat collects and where a ring traps moisture. A type IV reaction spreads — it can extend up the forearm past where the glove ended, which is the single most useful observation a clinic can record before referring the case onward.
What do the glove standards test — and what do they leave out?
This is where clinical staff and buyers both get misled. The standards are thorough about the glove as a device and quiet about the person inside it.
ASTM D6319 sets the specification for nitrile examination gloves: dimensions under measurement practice such as ASTM D3767, physical properties, and freedom from holes assessed by the water leak method in ASTM D5151 with batches sampled under a scheme such as ISO 2859-1. Those are the numbers that decide whether the glove is fit to be sold as a medical examination glove.
Chemical resistance is separate. ASTM D6978 covers permeation by chemotherapy drugs, and a clinic handling hazardous drugs needs a glove that carries that claim for the drugs on its list — not a glove that simply feels thick.
Skin compatibility is separate again, and it is where the confusion lives. ISO 10993-1 sets the biological evaluation framework, ISO 10993-10 addresses skin sensitization and ISO 10993-23 addresses irritation. These are extract-based laboratory methods with a population-level logic: they ask whether a material is likely to sensitise people in general. They cannot tell a clinic whether one hygienist will react to a particular production batch.
Quality-system standards close the loop on consistency rather than on skin. ISO 13485 governs how the manufacturer controls production, ISO 14971 how it manages risk, and ISO 15223-1 how the symbols on the box are defined. A glove made under a maintained quality system is more likely to have a consistent accelerator package, lot to lot. That consistency is worth something: a clinician who reacts to one lot and not the next is describing a manufacturing variation problem, not an allergy to nitrile.
Which glove should a reacting clinician try?
Change the chemistry, then change the fit, then change the habit — in that order.
The chemistry step means a glove from a different production line, not the same glove in a different colour. A powder-free nitrile made with a different accelerator package is the usual first trial. For clinics that need a glove with a chemotherapy permeation claim, that trial has to start from a glove that already carries the ASTM D6978 claim — a 4.0 mil powder-free chemo-grade nitrile glove is the reference point, because dropping the claim to solve a skin problem trades one hazard for another.
The fit step is underrated. A glove that is too tight at the knuckles concentrates friction exactly where the reaction appears, and clinicians routinely wear a size too small because that is what the cupboard held. Glove dimensions are set by ASTM D3767 measurement practice, so sizing is not a matter of opinion — measure the hand, then order accordingly.
The habit step is where most of the improvement actually comes from. Fewer unnecessary glove changes, dry hands before donning, and a hand-hygiene product that is not stripping the skin all reduce the irritant load that makes a sensitised clinician symptomatic. Where grip on wet instruments matters, a fully textured 5.0 mil glove such as the Aurelia Robust 5.0 mil powder-free glove lets a clinician drop a size rather than compensate with a tighter grip. Where the task is heavy instrument handling, a single heavier film such as the 6 mil heavy-duty black nitrile glove replaces layered thin gloves, and one layer of a heavier glove is easier on skin than two thin ones worn for the same four hours.
What belongs in a glove-reaction procedure?
Four fields and an owner, on one page. Anything longer does not get filled in.
- Who was affected: role, room, shift pattern, and the glove brand and lot in use.
- What happened: timing of onset, distribution, whether it spread beyond the glove line, and whether it improved away from work.
- What changed: glove line, hand-hygiene product, or frequency of changes, with the date.
- What was decided: continue, trial, refer, or escalate to the joint health and safety committee.
The owner is usually the office manager or the infection prevention lead, and the reason to name one is that glove complaints otherwise travel by conversation and vanish. Ontario's industrial establishments regulation requires PPE appropriate to the hazard and the maintenance of it in good condition, which is a floor rather than a ceiling; the occupational health argument is that a skin problem left unmanaged ends with a clinician working gloved for eight hours with broken skin, which is a worse infection-control position than the one the clinic started from.
How should a clinic run a switch without wasting a case?
Two weeks, one role, one case, and the symptom sheet still running.
Pick the role with the most glove hours — hygiene, phlebotomy, wound care — and give that group the trial line only. Keep the previous glove available so nobody improvises with a third brand. Review the sheet at the end of week two and ask the two questions that matter: did symptoms change, and did anyone quietly stop wearing the trial glove because of fit.
If the answer is yes and yes, the trial failed and the case is a small price for knowing. If symptoms eased, expand to the next role and keep the case-level reorder point so the change is visible on the supply sheet.
Bulk ordering terms for clinics changing a glove line sit on the wholesale and institutional account page, and the full nitrile range is listed in the B2B wholesale collection.
References
- ASTM D6319 — Standard Specification for Nitrile Examination Gloves for Medical Application (checked 30 October 2026)
- ASTM D5151 — Standard Test Method for Detection of Holes in Medical Gloves (checked 30 October 2026)
- ASTM D3767 — Standard Practice for Rubber — Measurement of Dimensions (checked 30 October 2026)
- ASTM D6978 — Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs (checked 30 October 2026)
- ISO 10993-10:2021 — Biological evaluation of medical devices, Part 10: tests for skin sensitization (checked 30 October 2026)
- ISO 10993-23:2021 — Biological evaluation of medical devices, Part 23: tests for irritation (checked 30 October 2026)
- ISO 10993-1:2025 — Biological evaluation of medical devices, Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process (checked 4 November 2026; supersedes ISO 10993-1:2018, withdrawn 18 November 2025)
- ISO 2859-1:1999 — Sampling procedures for inspection by attributes, Part 1: schemes indexed by acceptance quality limit (checked 30 October 2026)
- ISO 15223-1:2021 — Medical devices: symbols to be used with information to be supplied by the manufacturer (checked 30 October 2026)
- ISO 13485:2016 — Medical devices: quality management systems, requirements for regulatory purposes (checked 30 October 2026)
- ISO 14971:2019 — Medical devices: application of risk management to medical devices (checked 30 October 2026)
- Latex Allergy — CCOHS (checked 30 October 2026)
- Gloves — Selection and use — CCOHS (checked 30 October 2026)
- Routine Practices and Additional Precautions — Public Health Ontario (checked 30 October 2026)
- Hand Hygiene — Public Health Ontario (checked 30 October 2026)
- R.R.O. 1990, Regulation 851 — Industrial Establishments — Ontario e-Laws (checked 30 October 2026)
Printable companion: the free log and template centre includes a glove-change and skin-symptom sheet, so a reaction is recorded by room, task and glove lot rather than remembered after the fact.
Size the switch before you commit a case to it: the clinic supply and cost planner converts wears per role into boxes per month, so a change of glove line shows up as arithmetic instead of a surprise.
Related Reading
- Glove Contact Dermatitis: Type I Allergy vs Type IV Irritation
- Latex-Free Gloves for Healthcare: Allergy-Safe Options and Where to Order in Canada
Frequently Asked Questions
Can you be allergic to nitrile gloves?
Not to the nitrile polymer itself, in the way people are allergic to natural rubber latex protein. Nitrile contains no Hevea brasiliensis protein, so the immediate type I reaction that drives latex allergy is not the mechanism. What people react to in nitrile gloves is more often a residual chemical from manufacturing — a curing accelerator — or simply the occlusion and friction of wearing a sealed glove for hours. That is a different diagnosis with a different fix.
What are thiurams and carbamates doing in a glove?
They are vulcanisation accelerators. Nitrile film is cured so it holds its shape and elasticity, and accelerators control how fast and how evenly that cure happens. Thiurams and dithiocarbamates are common choices, and small residues remain in the finished film. Sweat inside the glove can leach those residues into contact with skin, which is why the reaction often appears where the glove touches most — knuckles, the dorsum of the hand, the wrist under the cuff.
How do I tell a type IV reaction from simple irritation?
Timing is the clearest signal. Irritant dermatitis usually appears where friction, sweat and soap sit — the web spaces and the palms — and it settles when the exposure stops. An allergic contact dermatitis of the delayed type typically appears 12 to 72 hours after exposure, spreads beyond the contact area, and can persist or worsen for days after the gloves come off. Itching and a raised, vesicular edge point away from plain irritation. Patch testing settles it; guessing does not.
Does switching to powder-free solve it?
It helps with one mechanism and not the other. Powder-free gloves remove the cornstarch that carried latex protein in the powdered era and reduce friction, so irritant cases often improve. They do not remove accelerators, so a genuine type IV reaction to a thiuram or a carbamate can continue in a powder-free glove made by the same process family.
Which glove should a reacting clinician try first?
One that changes the chemistry, not just the colour. A glove from a different manufacturing line with a different accelerator package, in a powder-free nitrile, at the lowest thickness that still suits the task, is the usual first step. Staff who handle chemotherapy need a glove tested to ASTM D6978 for permeation regardless of skin issues, so the switch has to preserve that requirement rather than replace it.
Does the medical glove standard test for skin reactions?
ASTM D6319 specifies the glove — dimensions, physical properties, freedom from holes sampled under a scheme such as ISO 2859-1 — and it is not a skin-compatibility document. Biological evaluation is handled separately, with ISO 10993-1 setting the framework and ISO 10993-10 and ISO 10993-23 covering sensitization and irritation testing. A glove can meet every requirement and still provoke a reaction in one wearer, because these tests are population-level screens, not personal predictions.
What should a clinic do when two staff react in the same month?
Treat it as an exposure question, not two unlucky people. Record the glove brand, lot, task and symptom for both, then look for what they share — the same box, the same dispensing station, the same shift pattern. Raise it through the joint health and safety committee, keep the records, and change something measurable: a different glove line for a trial period, more frequent glove changes, or a hand-hygiene product review, since repeated wet work and harsh soap make every glove reaction worse.
How many gloves should a clinic sample before switching the whole team?
A trial case, not a box. Fit, feel and grip change with the manufacturing line, and a clinician who dislikes a glove will not wear it correctly. Run one case through a single role for two weeks, keep the symptom sheet running, then decide. Buying a full year of gloves to save a small per-box difference is how clinics end up with a pallet nobody wants.
Last updated: October 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).